Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:22:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The change updates the page revision from v3.4.1 to v3.4.2, with no observed changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:58:01.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. This update does not affect study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-02-05T15:08:01.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays 'Last Update Posted' instead of 'Last Update Posted (Estimated)', removing the estimated tag from the update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-22T05:48:46.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new 'Last Update Posted (Estimated)' field was added and the revision label updated to 'v3.3.4', replacing the previous 'Last Update Posted' field and 'Revision: v3.3.3'.
    Difference
    0.1%
    Check dated 2026-01-15T02:42:48.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The Locations section was updated to show 11 locations, and the Miami Cancer Institute site was removed from the list.
    Difference
    0.4%
    Check dated 2026-01-08T01:37:33.000Z thumbnail image

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.